EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44

Bo Yang, Yongqing Mao, Yanjun Zhang, Yue Hao, Meitong Guo, Bian Li, Haisheng Peng

Molecules · 2023

DOI: 10.3390/molecules28227565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Bo Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Harbin University of Commerce, Harbin 150076, China. Hauptthemen laut MEDLINE: Nanoparticles, Colonic Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Harbin University of Commerce Youth Top Talent Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apigenin (API) possesses excellent antitumor properties but its limited water solubility and low bioavailability restrict its therapeutic impact. Thus, a suitable delivery system is needed to overcome these limitations and improve the therapeutic efficiency. Poly (lactic-co-glycolic acid) (PLGA) is a copolymer extensively utilized in drug delivery. Hyaluronic acid (HA) is a major extracellular matrix component and can specifically bind to CD44 on colon cancer cells. Herein, we aimed to prepare receptor-selective HA-coated PLGA nanoparticles (HA-PLGA-API-NPs) for colon cancers with high expression of CD44; chitosan (CS) was introduced into the system as an intermediate, simultaneously binding HA and PLGA through electrostatic interaction to facilitate a tighter connection between them. API was encapsulated in PLGA to obtain PLGA-API-NPs, which were then sequentially coated with CS and HA to form HA-PLGA-API-NPs. HA-PLGA-API-NPs had a stronger sustained-release capability. The cellular uptake of HA-PLGA-API-NPs was enhanced in HT-29 cells with high expression of CD44. In vivo, HA-PLGA-API-NPs showed enhanced targeting specificity towards the HT-29 ectopic tumor model in nude mice in comparison with PLGA-API-NPs. Overall, HA-PLGA-API-NPs were an effective drug delivery platform for API in the treatment of colon cancers with high expression of CD44.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesColonic NeoplasmsAnimalsMiceHyaluronic AcidApigeninMice, NudeDrug CarriersCell Line, Tumor

Stichwörter der Autor:innen

APICD44HAPLGA nanoparticlescolon cancertargeted delivery

Substanzen

Hyaluronic AcidApigeninDrug Carriers

Autor:innen und Institutionen

  • School of Pharmacy, Harbin University of Commerce, Harbin 150076, China.
  • Department of Pharmacology, Medical College, University of Shaoxing, Shaoxing 312000, China.
  • Heilongjiang Provincial Key Laboratory of Neurobiology, Department of Neurobiology, Harbin Medical University, Harbin 150086, China.

Förderung

  • Harbin University of Commerce Youth Top Talent Program

Zitieren

APA

Yang, B., Mao, Y., Zhang, Y., Hao, Y., Guo, M., Li, B., & Peng, H. (2023). HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44. Molecules. https://doi.org/10.3390/molecules28227565

Vancouver

Yang B, Mao Y, Zhang Y, Hao Y, Guo M, Li B, et al. HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44. Molecules. 2023. doi:10.3390/molecules28227565

BibTeX
@article{Yang2023,
  author = {Yang, Bo and Mao, Yongqing and Zhang, Yanjun and Hao, Yue and Guo, Meitong and Li, Bian and Peng, Haisheng},
  title = {HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28227565}
}
Kostenlos starten →